Recent advances in RASopathies

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Human Genetics

• Publication date

  2015-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/jhg.2015.114PMID 26446362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurofibromatosis 1 -- GeneReviews(®)

  2016cited by this paper
• RASA1-Related Disorders

  2016cited by this paper
• Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: Palliative treatment with a rapamycin analog

  2015cited by this paper
• Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome

  2015cited by this paper
• Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis

  2014cited by this paper
• Comprehensive molecular profiling of lung adenocarcinoma

  2014cited by this paper
• Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: Four new cases and further evidence of heterogeneity

  2014cited by this paper
• Cardio-Facio-Cutaneous Syndrome: Clinical Features, Diagnosis, and Management Guidelines

  2014cited by this paper
• Next-generation sequencing identifies rare variants associated with Noonan syndrome

  2014cited by this paper
• Oncogenic RIT1 mutations in lung adenocarcinoma

  2014cited by this paper
• New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.

  2014cited by this paper
• Phenotypic variability associated with the invariant SHOC2 c.4A>G (p.Ser2Gly) missense mutation

  2014cited by this paper
• Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome

  2014cited by this paper
• Further evidence of the importance of RIT1 in Noonan syndrome

  2014cited by this paper
• Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas

  2013cited by this paper
• Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies

  2013cited by this paper
• Anti-α-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus.

  2013cited by this paper
• The RASopathies.

  2013cited by this paper
• Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.

  2013cited by this paper
• RASA1 Mutations and Associated Phenotypes in 68 Families with Capillary Malformation–Arteriovenous Malformation

  2013cited by this paper
• The integrated landscape of driver genomic alterations in glioblastoma

  2013cited by this paper
• Review and update of SPRED1 mutations causing legius syndrome

  2012cited by this paper
• LEOPARD Syndrome: Clinical Features and Gene Mutations

  2012cited by this paper
• PTPN11-associated mutations in the heart: has LEOPARD changed Its RASpots?

  2011cited by this paper
• MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.

  2011cited by this paper
• Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype?

  2011cited by this paper
• Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

  2011cited by this paper
• Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome

  2011cited by this paper
• Costello and cardio‐facio‐cutaneous syndromes: Moving toward clinical trials in RASopathies

  2011cited by this paper
• The Protease Inhibitor Alpha-2-Macroglobuline-Like-1 Is the p170 Antigen Recognized by Paraneoplastic Pemphigus Autoantibodies in Human

  2010cited by this paper
• Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

  2010cited by this paper
• Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia

  2010cited by this paper
• Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines

  2010cited by this paper
• Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.

  2010cited by this paper
• Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies

  2010cited by this paper
• Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.

  2010cited by this paper
• A restricted spectrum of NRAS mutations causes Noonan syndrome

  2010cited by this paper
• Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation

  2010cited by this paper
• Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair

  2009cited by this paper
• Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum

  2009cited by this paper
• Mutation in SHOC2 promotes aberrant protein N-myristoylation and underlies Noonan-like syndrome with loose anagen hair

  2009cited by this paper
• The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.

  2009cited by this paper
• Binding of α2ML1 to the Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) Reveals a New Role for LRP1 in the Human Epidermis

  2008cited by this paper
• The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders

  2008cited by this paper
• Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.

  2008cited by this paper
• Germline gain-of-function mutations in RAF1 cause Noonan syndrome

  2007cited by this paper
• Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

  2007cited by this paper
• Noonan syndrome

  2007cited by this paper
• Germline gain-of-function mutations in SOS1 cause Noonan syndrome

  2007cited by this paper
• Molecular and clinical characterization of cardio‐facio‐cutaneous (CFC) syndrome: Overlapping clinical manifestations with Costello syndrome

  2007cited by this paper
• Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype

  2007cited by this paper
• Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results.

  2007cited by this paper
• PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects*

  2006cited by this paper
• A Novel Protease Inhibitor of the α2-Macroglobulin Family Expressed in the Human Epidermis*

  2006cited by this paper
• Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

  2006cited by this paper
• Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.

  2006cited by this paper
• Germline KRAS mutations cause Noonan syndrome

  2006cited by this paper
• Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome

  2006cited by this paper
• Reduced phosphatase activity of SHP‐2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1

  2006cited by this paper
• Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome

  2006cited by this paper
• Germline mutations in HRAS proto-oncogene cause Costello syndrome

  2005cited by this paper
• Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta).

  2005cited by this paper
• Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Controls Endocytosis and c-CBL-mediated Ubiquitination of the Platelet-derived Growth Factor Receptor β (PDGFRβ)*

  2005cited by this paper
• Blood pressure and cardiovascular involvement in children with neurofibromatosis type1

  2004cited by this paper
• RAS oncogenes: the first 30 years

  2003cited by this paper
• Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.

  2003cited by this paper
• A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1.

  2002cited by this paper
• Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

  2002cited by this paper
• Induction of Neurite Extension and Survival in Pheochromocytoma Cells by the Rit GTPase*

  2002cited by this paper
• Potent transforming activity of the small GTP‐binding protein Rit in NIH 3T3 cells: evidence for a role of a p38γ‐dependent signaling pathway

  2002cited by this paper
• Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

  2002cited by this paper
• Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

  2001cited by this paper
• Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways

  2000cited by this paper
• The Ras branch of small GTPases: Ras family members don't fall far from the tree.

  2000cited by this paper
• Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

  2000cited by this paper
• Rin, a Neuron-Specific and Calmodulin-Binding Small G-Protein, and Rit Define a Novel Subfamily of Ras Proteins

  1996cited by this paper
• RIC, a calmodulin‐binding Ras‐like GTPase.

  1996cited by this paper
• Isolation and characterization of a novel gene deleted in DiGeorge syndrome.

  1995cited by this paper
• Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

  1990cited by this paper
• Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

  1990cited by this paper
• Noonan syndrome: the changing phenotype.

  1985cited by this paper
• Effect of Simvastatin on Cognitive Functioning in Children with Neurofibromatosis Type 1 a Randomized Controlled Trial

  year unknowncited by this paper

• Noonan syndrome spectrum disorders in real life: patient characteristics and response to growth hormone therapy in a genetically defined single-country multicenter cohort

  2026cites this paper
• Neonatal-Onset Noonan Syndrome: Two Cases Reports and Literature Review

  2025cites this paper
• Heterogeneity of Orodental Features in a Family with Noonan Syndrome

  2025cites this paper
• Phenotypic Analysis of Embryos in a Noonan Syndrome Model Mouse With the Rit1 A57G Mutation

  2025influential citation
• Optimized conditions for GTP loading of Ras

  2025cites this paper
• Recurrent cellulitis associated with lymphoedema in Noonan syndrome: case reports with RIT1 variants and literature review

  2025cites this paper
• JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease.

  2025cites this paper
• LZTR1: c.1260+1del Variant as a Significant Predictor of Early-Age Breast Cancer Development: Case Report Combined with In Silico Analysis

  2025cites this paper
• Lztr1 deficiency contributes to the pathogenesis of dilated cardiomyopathy via RAP1/PI3K/AKT-mediated myocardial Injury.

  2025cites this paper
• Non‐RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome

  2025cites this paper
• M-Ras distinct activation scenarios: A mechanistic outlook and targeting

  2025cites this paper
• Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?

  2025cites this paper
• Advancing edge-based clustering and graph embedding for biological network analysis: a case study in RASopathies

  2025cites this paper
• Central Conducting Lymphatic Abnormalities in Noonan Syndrome Identified Using SPECT/CT Lymphoscintigraphy

  2025cites this paper
• Efficacy of Sirolimus in Treating Refractory Lymphatic Malformation in Noonan Syndrome: A Case Study

  2025cites this paper
• The HRAS Variant c.175G>A (p.Ala59Thr) Causes a Predominantly Ectodermal Phenotype Lacking Classic Costello Syndrome Features

  2025cites this paper
• Costello Syndrome and Ophthalmologic Issues: Unveiling the Unseen

  2025cites this paper
• The tumor suppressor LZTR1: Its expression, purification and characterization.

  2025cites this paper
• Exploring the genetic alterations of Gorham-Stout disease

  2025cites this paper
• RASopathies. Part I: Genetics and therapeutic considerations.

  2025cites this paper
• RASopathies and Cardiac Complications: Insights into Mechanisms, Diagnosis, and Innovative Treatments.

  2025cites this paper
• Yield of RASopathy Gene Panel in Karyotype-Normal or Microarray-Normal Fetuses With Increased Nuchal Translucency

  2025cites this paper
• Serum Markers of Bone Turnover and Bone Remodeling in Children with Noonan Syndrome: Genotype-Phenotype Correlation

  2025cites this paper
• Exploring the clinical complexity of cardio-facio-cutaneous syndrome: insights from a pediatric case series

  2024cites this paper
• Microbial Metagenomes and Host Transcriptomes Reveal the Dynamic Changes of Rumen Gene Expression, Microbial Colonization and Co-Regulation of Mineral Element Metabolism in Yaks from Birth to Adulthood

  2024cites this paper
• Orbital and Lumbosacral Plexiform Neurofibroma with PTPN11 Mutation: A Form of the RASopathy

  2024cites this paper
• Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature

  2024cites this paper
• Gonadal dysfunction in a man with Noonan syndrome from the LZTR1 variant: case report and review of literature.

  2024cites this paper
• Craniofacial disorders and dysplasias: Molecular, clinical, and management perspectives

  2024cites this paper
• Functional analysis of RRAS2 pathogenic variants with a Noonan-like phenotype

  2024cites this paper
• Dysregulation of RAS proteostasis by autosomal-dominant LZTR1 mutation induces Noonan syndrome–like phenotypes in mice

  2024cites this paper
• LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome

  2024cites this paper
• Noonan Syndrome Growth Charts and Genotypes: 15-Year Longitudinal Single-Centre Study

  2024influential citation
• Prenatal Sonographic Features of Noonan Syndrome: Case Series and Literature Review

  2024cites this paper
• Autopsy case of linear nevus sebaceous syndrome with KRAS (G12D) mutation

  2024cites this paper
• RASopathies in Cardiac Disease.

  2024cites this paper
• Genetic backgrounds and genotype-phenotype relationships in anthropometric parameters of 116 Japanese individuals with Noonan syndrome

  2024cites this paper
• MEK inhibition in Noonan syndrome patient with severe cardiovascular and lymphatic disease

  2024cites this paper
• HYPERTROPHIC CARDIOMYOPATHY IN TEENAGER WITH LEOPARD SYNDROME (CLINICAL CASE)

  2024cites this paper
• Noonan and RAS/MAPK Syndromes in Pediatric Cardiology: A Review

  2024cites this paper
• JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease.

  2024cites this paper
• Parenting Stress Index in Caregivers of Individuals With Noonan Syndrome

  2024cites this paper
• Evaluation of information flows in the RAS-MAPK system using transfer entropy measurements

  2024cites this paper
• Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome.

  2024cites this paper
• Management of hypertrophic cardiomyopathy

  2024cites this paper
• New Insights Into the Spectrum of RASopathies: Clinical and Genetic Data in a Cohort of 121 Spanish Patients

  2024cites this paper
• Germline mutations in a G protein identify signaling cross-talk in T cells

  2024cites this paper
• The Role of Neuromuscular Ultrasound in the Diagnosis of Peripheral Neuropathy

  2024cites this paper
• Twins with psychiatric features and a nonsense HRAS variant affecting transcript processing

  2023cites this paper
• Genetically Encoded Aminocoumarin Lysine for Optical Control of Protein–Nucleotide Interactions in Zebrafish Embryos

  2023cites this paper
• The Genetics of Canine Pulmonary Valve Stenosis.

  2023cites this paper
• LZTR1 deficiency exerts high metastatic potential by enhancing sensitivity to EMT induction and controlling KLHL12-mediated collagen secretion

  2023cites this paper
• The exocyst complex in neurological disorders

  2023cites this paper
• The “FEEDS (FEeding Eating Deglutition Skills)” over Time Study in Cardiofaciocutaneous Syndrome

  2023cites this paper
• Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene

  2023cites this paper
• Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition

  2023cites this paper
• Genetic diseases: How the noise fits in.

  2023cites this paper
• Esophageal Granular Cell Tumor in Children: A Clinicopathologic Study of 11 Cases and Review of the Literature.

  2023cites this paper
• RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy

  2023influential citation
• Systematic ophthalmologic evaluation in cardio‐facio‐cutaneous syndrome: A genotype–endophenotype correlation

  2023cites this paper
• RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis

  2023cites this paper
• KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2

  2023cites this paper
• Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes

  2023cites this paper
• Differences in severity of cardiovascular anomalies in children with Noonan syndrome based on the causative gene

  2022cites this paper
• Noonan syndrome caused by RIT1 gene mutation: A case report and literature review

  2022cites this paper
• Male infant with Noonan syndrome with RAF-1 gene mutation who survived hypertrophic cardiomyopathy-induced fatal heart failure and uncontrollable arrhythmias

  2022cites this paper
• Genome-wide CRISPR/Cas9 Screens Reveal Shared and Bespoke Mechanisms of Resistance to SHP2 inhibition

  2022influential citation
• Prevalence of gastrointestinal disorders in individuals with RASopathies: May RAS/MAP/ERK pathway dysfunctions be a model of neuropathic pain and visceral hypersensitivity?

  2022cites this paper
• Myocardial hypertrophy in a newborn from an unknown pregnancy

  2022cites this paper
• Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease

  2022cites this paper
• Molecular characterization using exome sequencing of two probands with the undiagnosed developmental delay from Central Brazil

  2022cites this paper
• Lymphatic Anomalies in Children: Update on Imaging Diagnosis, Genetics and Treatment.

  2022cites this paper
• Giant Cell Lesions of the Jaws Involving RASopathy Syndromes

  2022influential citation
• Cardiovascular Abnormalities and Gene Mutations in Children With Noonan Syndrome

  2022influential citation
• The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma

  2022cites this paper
• Clinical Findings in Children with Noonan Syndrome—A 17-Year Retrospective Study in an Oral Surgery Center

  2022cites this paper
• Recent advances in understanding the roles of whole genome duplications in evolution [version 1; peer review: 2 approved]

  2022cites this paper
• Neurological features of Noonan syndrome and related RASopathies: Pain and nerve enlargement characterized by nerve ultrasound

  2022cites this paper
• Ras-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy

  2022influential citation
• NSD1 mutations deregulate transcription and DNA methylation of bivalent developmental genes in Sotos syndrome

  2022cites this paper
• Induced pluripotent stem cells for modeling Noonan, Noonan Syndrome with Multiple Lentigines, and Costello Syndromes

  2022cites this paper
• The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells

  2022cites this paper
• Extending the prenatal Noonan's phenotype by review of ultrasound and autopsy data

  2022cites this paper
• The genomic landscape across 474 surgically accessible epileptogenic human brain lesions

  2022cites this paper
• A Genetic Approach in the Evaluation of Short Stature

  2022cites this paper
• Molecular advances, clinical management, and treatment opportunities in RASopathies

  2022cites this paper
• New insights on Noonan syndrome’s clinical phenotype: a single center retrospective study

  2022cites this paper
• Management of nutritional and gastrointestinal issues in RASopathies: A narrative review

  2022cites this paper
• The molecular genetics of RASopathies: An update on novel disease genes and new disorders

  2022cites this paper
• Delineating the autistic phenotype in children with neurofibromatosis type 1

  2022cites this paper
• Kaposiform lymphangiomatosis presenting with a Group A Streptococcus pericardial effusion

  2022cites this paper
• Genetics of Neurocutaneous Syndromes

  2022cites this paper
• A Progeroid Syndrome Caused by RAF1 deficiency Underscores the importance of RTK signaling for Human Development

  2022cites this paper
• Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status

  2022cites this paper
• The complex, dynamic SpliceOme of the small GTPase transcripts altered by technique, sex, genetics, tissue specificity, and RNA base editing

  2022cites this paper
• RASopathy Cohort of Patients Enrolled in a Brazilian Reference Center for Rare Diseases: A Novel Familial LZTR1 Variant and Recurrent Mutations

  2022cites this paper
• The heart in RASopathies

  2022cites this paper
• Refractory thrombocytopenia could be a rare initial presentation of Noonan syndrome in newborn infants: a case report and literature review

  2022cites this paper
• Multidisciplinary Management of Costello Syndrome: Current Perspectives

  2022cites this paper
• Case report: The cardio-facio-cutaneous syndrome due to a novel germline mutation in MAP2K1: A multifaceted disease with immunodeficiency and short stature

  2022cites this paper